ARCHIVES

Olaparib, A PARP Inhibitor, Can Reduce Tumor Size In Advanced Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 33 No. 8 | August 27, 2010

Download PDF Visit The Full Archive

Related Articles

NIH News: NTP To test Herbs for Toxicity

August 13, 1999

ACS Plans To Review Prostate Cancer Screening Guideline

March 20, 2009

New Cancer Survival, Incidence, Mortality Statistics Cause for Optimism, Concern

February 12, 1988

Biomedical Panel Says Cancer Panel Should Expand to Serve all NIH

June 4, 1976

AVEO’s Tivozanib Sunk by Fundamental Flaw: Higher Overall Survival in the Control Arm

May 8, 2013

Senate Gives NIH Director Authority To Permit Research By Unconventional MDs

September 25, 1992